Advances in HIV treatment and prevention: should treatment optimism lead to prevention pessimism?

被引:21
|
作者
Lert, F [1 ]
机构
[1] INSERM, U88, F-94415 St Maurice, France
关键词
D O I
10.1080/09540120020014291
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Advances in HIV treatment have changed the natural history of HIV disease and improved the life of infected people. But, paradoxically, the transformation of a lethal disease into a chronic condition has lead many people to pessimism regarding the future of HIV prevention. Post-exposure prophylaxis and prophylaxis of vertical transmission have added new tools, although they do not change the main features of HIV prevention which still relies on safer drug use and safer sex. The role assigned to HIV resting starred to change in some countries where it had not been encouraged; however the impact of these changes appears still very limited, except for prevention of vertical transmission. Recent developments should be placed in the whole historical perspective of HIV infections after the early period of dramatic favourable changes (around 1990), positive changes in attitudes and behaviour have slowed down or even stabilized. Proofs of 'relapse' are, however, still tenuous. The impact of therapeutic changes is combined with the normalization process of HIV infection issues. In the general population, HIV infection seems a more remote personal and social concern and the perception of risk has decreased. The changes in the social context of prevention are more diverse. On one hand, some social norms renewed during the HIV era may have long-lasting effects. The acknowledgement of social and human rights of homosexuals and drug users, stimulated by the AIDS movement, has entered a long-term process and may continue to support preventive behaviours. On the other hand, the exceptionalist alliance which supported and stimulated the HIV policies is weakening. This process might be accelerated by improved therapeutic perspectives. The main challenge is the success of the integration of HIV prevention in broader public health policies (including prevention of STI transmission, family planning, health promotion, etc.) without losing advances in prevention strategies gained in the HIV/AIDS era.
引用
收藏
页码:745 / 755
页数:11
相关论文
共 50 条
  • [21] Treatment as prevention for HIV: a reality
    Blaxhult, Anders
    Bratt, Goran
    [J]. AIDS, 2015, 29 (13) : 1721 - 1721
  • [22] Achievability of HIV treatment as prevention
    Lee, Shui Shan
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S55 - S55
  • [23] How HIV treatment advances affect the cost-effectiveness of prevention
    Pinkerton, SD
    Holtgrave, DR
    [J]. MEDICAL DECISION MAKING, 2000, 20 (01) : 89 - 94
  • [24] Global Response to HIV: Treatment as Prevention, or Treatment for Treatment?
    Sigaloff, Kim C. E.
    Lange, Joep M. A.
    Montaner, Julio
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 : S7 - S11
  • [25] HIV PREVENTION FATIGUE AND HIV TREATMENT OPTIMISM AMONG YOUNG MEN WHO HAVE SEX WITH MEN
    Macapagal, Kathryn
    Birkett, Michelle
    Janulis, Patrick
    Garofalo, Robert
    Mustanski, Brian
    [J]. AIDS EDUCATION AND PREVENTION, 2017, 29 (04) : 289 - 301
  • [26] Prevention With People With HIV in the United States: The Nexus of HIV Prevention and Treatment
    Kilmarx, Peter H.
    Mermin, Jonathan
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 (03) : 219 - 220
  • [27] Recent Advances in Antifungal Prevention and Treatment
    Groll, Andreas H.
    Tragiannidis, Athanasios
    [J]. SEMINARS IN HEMATOLOGY, 2009, 46 (03) : 212 - 229
  • [28] Advances in the prevention and treatment of lung cancer
    Hodkinson, P. S.
    Sethi, T.
    [J]. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2011, 41 (02): : 142 - 149
  • [29] Advances in the treatment and prevention of Lyme borreliosis
    Wormser, GP
    Stanek, G
    Strle, F
    Gray, JS
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (11-12) : 381 - 384
  • [30] Advances in the prevention and treatment of cardiovascular disease
    Weisfeldt, Myron L.
    Zieman, Susan J.
    [J]. HEALTH AFFAIRS, 2007, 26 (01) : 25 - 37